Mounjaro (Tirzepatide) is a newer weight loss medication that works differently from many other weight loss drugs
doi: 10.1038/s41467-022-34581-2
Beyond weight reduction alone, these trials have also shown improvements across a range of cardiometabolic markers, including blood pressure, lipid profiles, glycemic control, and inflammatory measures
Mechanism of Action IGF-1 LR3 has been investigated for its agonist activity at the type 1 IGF receptor (IGF-1R), a receptor tyrosine kinase
This blend should please both sides of the debate
Less commonly, alopecia areata, traction alopecia, diffuse unpatterned alopecia, or an inflammatory or scarring disorder may be responsible